欧美日本成人_亚洲一区二区日本_国产污视频在线观看_先锋影视av_99视频+国产日韩欧美_黄页视频在线免费观看_天海翼av在线播放_在线视频精品免费_黄色一级片免费在线观看_国内精品久久久久久久_av动漫网站_日本a级大片

近年來(lái)越來(lái)越多的科研人員開(kāi)始對(duì)生物信息學(xué)感興趣，生物信息學(xué)相關(guān)文章更是逐年上升?？陕某霈F(xiàn)了“生信文章現(xiàn)在很難發(fā)了”的感慨和質(zhì)疑，那么如何選擇一本合適的期刊也變得尤其重要，今天小編就來(lái)推薦一些小編心中生信友好期刊，快來(lái)看看吧。

Molecular Cancer

2002年創(chuàng)刊的Molecular Cancer雜志，在影響因子層面一路高歌猛進(jìn)，目前IF = 27.401，其主要接收靶向治療、分子與細(xì)胞生物學(xué)、基因組學(xué)、遺傳學(xué)、病理與腫瘤免疫學(xué)等領(lǐng)域相關(guān)的學(xué)術(shù)論文。主要以論著和綜述為主，Letter數(shù)量近年略有增加。

Molecular Cancer雜志中包含了很多熱點(diǎn)方向的生信分析文章，如RNA修飾的相關(guān)文章“Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer”；m6A的相關(guān)文章“m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer”和“Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types”；腫瘤抗原的相關(guān)文章“Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development”和“Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development”等等。

Clinical Cancer Research

1995年創(chuàng)刊的Clinical Cancer Research雜志，在影響因子層面一直較為穩(wěn)定，目前IF = 12.531，其主要接收靶向治療的臨床與轉(zhuǎn)化研究，藥物敏感性和耐藥性機(jī)制，遺傳藥理學(xué)和藥物基因組學(xué)，個(gè)性化醫(yī)學(xué)，生物信息學(xué)和生物統(tǒng)計(jì)學(xué)應(yīng)用，免疫治療和臨床免疫學(xué)，人類腫瘤分子表征和診斷生物標(biāo)志物等領(lǐng)域相關(guān)的學(xué)術(shù)論文。主要以論著為主，另包含少部分letter、review等類別文章。

Clinical Cancer Research雜志中包含了很多熱點(diǎn)方向的生信分析文章，如免疫與預(yù)后的相關(guān)文章“An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy”和“An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma”；免疫治療的相關(guān)文章“Myeloid Cell–associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing”；單細(xì)胞數(shù)據(jù)的相關(guān)文章“Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance”和“Single-Cell Genomic Characterization Reveals the Cellular Reprogramming of the Gastric Tumor Microenvironment”等等。

Briefings in Bioinformatics

2000年創(chuàng)刊的Briefings in Bioinformatics雜志，在影響因子層面穩(wěn)步上升，目前IF = 11.622，其主要接收表型和基因型的遺傳研究、DNA測(cè)序、代謝和信號(hào)通路、結(jié)構(gòu)確定和功能預(yù)測(cè)、蛋白質(zhì)組學(xué)、生信數(shù)據(jù)庫(kù)和分析工具等領(lǐng)域相關(guān)的學(xué)術(shù)論文，與有關(guān)生信新工具、數(shù)據(jù)庫(kù)和新方法居多，以及部分純生信的分析文章。

Briefings in Bioinformatics雜志中包含了很多熱點(diǎn)方向的生信分析文章，如免疫與預(yù)后的相關(guān)文章“Clinical significance and immunogenomic landscape analyses of the immune cell signature based prognostic model for patients with breast cancer”和“Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response”；篩選基因標(biāo)志物的相關(guān)文章“A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma”和“Pan-cancer application of a lung-adenocarcinoma-derived gene-expression-based prognostic predictor”；可變剪切的相關(guān)文章“Comprehensive characterization of alternative splicing in renal cell carcinoma”；單細(xì)胞數(shù)據(jù)的相關(guān)文章“Comprehensive analysis of partial methylation domains in colorectal cancer based on single-cell methylation profiles”等等。

OncoImmunology

2012年創(chuàng)刊的OncoImmunology雜志，在影響因子層面略有降低但保持在5分以上，目前IF = 8.110，其主要接收腫瘤免疫學(xué)的轉(zhuǎn)化與臨床研究、癌癥治療和免疫治療等領(lǐng)域相關(guān)的學(xué)術(shù)論文。主要以論著為主，其他類別文章占10-15%。

OncoImmunology雜志中包含了很多熱點(diǎn)方向的生信分析文章，如免疫治療的相關(guān)文章“Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinoma”；新抗原的相關(guān)文章“HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer”；患者生存的相關(guān)文章“Age-related mutational signature negatively associated with immune activity and survival outcome in triple-negative breast cancer”和“Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinoma”等等。

Frontiers In Immunology

2010年創(chuàng)刊的Frontiers In Immunology雜志，在影響因子層面略有波動(dòng)，除2018年外基本維持在5分以上，目前IF = 7.561，其主要接收同種免疫和移植、抗原提呈細(xì)胞生物學(xué)、自身免疫性疾病和自身炎癥疾病、B細(xì)胞生物學(xué)、癌癥免疫治療、比較免疫學(xué)、細(xì)胞因子和免疫中的可溶性介體、免疫記憶、免疫耐受和調(diào)節(jié)、炎癥、微生物免疫學(xué)、分子先天免疫、粘膜免疫、多發(fā)性硬化癥和神經(jīng)免疫學(xué)、NK和先天淋巴樣細(xì)胞生物學(xué)、營(yíng)養(yǎng)免疫學(xué)、原發(fā)性免疫缺陷、T細(xì)胞生物學(xué)、疫苗和分子治療學(xué)、病毒免疫學(xué)等領(lǐng)域相關(guān)的學(xué)術(shù)論文。文章類型主要以論著和綜述為主。

Frontiers In Immunology雜志中包含了很多熱點(diǎn)方向的生信分析文章，如單基因泛癌分析的相關(guān)文章“A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint”；m6A、缺氧、自噬等熱點(diǎn)內(nèi)容的相關(guān)文章“Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma”、 “Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma”和“Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature”；識(shí)別預(yù)后標(biāo)記物的相關(guān)文章“Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma”和“A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis”；識(shí)別分子亞型的相關(guān)文章“Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy”等等。

除了上述5個(gè)雜志，小編還將其他生信友好期刊進(jìn)行了整理，對(duì)比近兩年的影響因子，以便于小伙伴們選出適合自己文章的雜志。

快來(lái)使用生信人開(kāi)發(fā)的文獻(xiàn)下載利器paperneed(https://paperneed.cn/)查文獻(xiàn)、查期刊，為自己的工作選擇一個(gè)適合的雜志吧~